PORO TECHNOLOGIES LTD

private

Total Raised

$6,328,978

Contracts

Patents

PAC Giving

Government Contracts & Awards

No recent government contracts or awards found.

Proprietary Tech & Patents

METHOD OF CONTROLLING BOW IN A SEMICONDUCTOR STRUCTURE, SEMICONDUCTOR STRUCTURE, AND SEMICONDUCTOR DEVICE

US 12684904 Jul 14, 2026

Form D Funding

Private Placement

Jun 5, 2026

$6,328,978Raised

Market Intelligence & News

Yahoo Jun 15, 2026

ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)

The pharmacokinetic (PK) and pharmacodynamic (PD) profiles of single tablet EB613, multi-tablet EB613 and Forteo® reported for the first time as an oral presentation at ENDO 2026 Single tablet EB613 achieved a comparable PK/PD profile to Forteo® and multi-tablet EB613, which was evaluated in Entera’s Phase 2 study in postmenopausal women with osteoporosis and low bone mass This major scientific achievement supports advancing single tablet EB613 into Entera’s planned Phase 3 study of EB613 in pos

Key People

No individuals linked to this entity yet.

Political Giving

No disclosed PAC contributions found for this entity.

Factual Connections

Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.

Upgrade to Pro